Skip to main content
. 2024 Jan 12;15(3):408–446. doi: 10.1021/acschemneuro.3c00532

Table 5. Highlighted mTOR Inhibition Antiaging Clinical Trials.

indication intervention status sponsor NCT no.
Geographic atrophy Rapamycin Complete National Eye Institute, USA NCT01445548
Aging frailty Rapamycin Complete Mayo Clinic, USA NCT01649960
Aging/epigenetics/inflammatory mediators Rapamycin Active, not recruiting The University of Texas Health Science Center, USA NCT04608448
Age-related sarcopenia Rapamycin|resistance exercise Recruiting University of Nottingham, U.K. NCT05414292